… report is to provide a detailed overview of molnupiravir, an oral and novel RdRp inhibitor. …
In summary, these studies indicate that oral molnupiravir is highly effective in reducing …

… available oral anti-SARS-CoV-2 candidates, as a new hope to end the current pandemic. …
, on the other hand, assessed inhaled ribavirin preparation as a sole agent. Citation100 …

… Molnupiravir (MOV) is a broad-spectrum oral antiviral agent … Molnupiravir for oral
treatment of covid-19 in nonhospitalized … and safety of three new oral antiviral treatment (molnupiravir, …

… or other antiviral biological agents such as convalescent … developed a new strategy to
synthesize molnupiravir using … partly explain why the anti-SARS-CoV-2 activity of remdesivir in …

… drug–transporter interactions of Molnupiravir, Nirmatrelvir, and … In the case of the nucleoside
analog Molnupiravir, we included … side effects of these widely used anti-COVID-19 agents. …

… oral antiviral agents are still lacking. In the present review, the potential beneficial effects of
molnupiravir in … be considered as disadvantages of anti-SARS-CoV-2 monoclonal antibodies. …

… Anti-SARS-CoV-2 treatment for patients with a suspected or confirmed COVID-19 infection …
In this study, NHC was described as a potent anti-VEEV agent, with an EC50 below 1 μM and …

… It is rapidly converted into its active form after oral … on molnupiravir, a nucleoside prodrug,
and its active metabolites, which exhibit promise as broad-spectrum anti-SARS-CoV-2 agents …

… Merck and Ridgeback Bio collaborate to develop of a new … new synthetic pathway of
molnupiravir as an anti-viral agent to … -2, molnupiravir has shown strong anti-SARS-CoV-2 activity …

… molnupiravir), and compliance with ingestion of a high number of pills. Knowledge gaps include
the efficacy of these agents … , anti-SARS-CoV-2 monoclonal antibody plus oral antivirals) …